Document is current

Comparison of adverse effects among different GLP-1 receptor agonists added to basal insulin, and between GLP-1 receptor agonists and basal insulin versus Basal-plus or basal-bolus insulin in type 2 diabetes: A meta-analysis

Crossref DOI link: https://doi.org/10.30574/wjarr.2021.10.2.0215

Published Online: 2021-05-30

Update policy: https://doi.org/10.30574/wjarr.ourcrossmarkpolicy